Targeting T-Cells in Multiple Myeloma May Be Focus For New Clinical Trials

Targeting T-Cells in Multiple Myeloma May Be Focus For New Clinical Trials

User Photo
ASHReport

3 years
642 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
David M. Foureau, PhD of Levine Cancer Institute discusses how targeting T-cells in myeloma may be the new focus for clinical trials at the 58th ASH Annual Meeting in San Diego, CA.
Up Next Autoplay